Lloyds Enterprises Regulatory Approval

Earnings Call

Lloyds Enterprises Investor Presentation: Key Takeaways

Q2 FY27 consolidated income ₹738 Cr (+65% YoY); H1 income ₹1,343 Cr (+27%), EBITDA ₹224.82 Cr, margin 16.74%. Real estate demerger into Lloyds Realty Ltd underway.

Financial Results

Lloyds Enterprises Q2 FY27 Results: Net Profit ₹58.2 Cr, Down 5.8% YoY

Lloyds Enterprises Ltd reported revenue from operations of ₹693.9 Cr (+70.7% YoY) and net profit of ₹58.2 Cr (-5.8% YoY) for Q2 FY27.

Key figure

Net profit ₹58.2 Cr · -5.8% YoY

Board Meeting Date

Lloyds Enterprises Board Meeting Date

Lloyds Enterprises scheduled its Board meeting for November 5, 2026, to approve unaudited results and forfeiture of partly paid-up shares. No monetary figures disclosed.

Other Announcement

Lloyds Enterprises Other Announcement

Lloyds Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.

Employee Stock Options

Lloyds Enterprises Employee Stock Options

Lloyds Enterprises granted 1,35,440 ESOPs under its 2025 plan at Rs. 2 per option. Options carry a one-year minimum vesting and three-year exercise window.

Price Movement Clarification

Lloyds Enterprises Price Movement Clarification

Lloyds Enterprises Limited clarified that the recent increase in share trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information at this time.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.